Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
MDG1011 is T lymphocytes engineered to express preferentially expressed antigen in melanoma (PRAME)-specific TCR coupled to the CD3 signaling complex, which may induce death of PRAME-expressing tumor cells (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|